
### [MONDO:0020037](http://purl.obolibrary.org/obo/MONDO_0020037)
**Label:** rare gynecological tumor

**Subclasses:** [MONDO:0015873](http://purl.obolibrary.org/obo/MONDO_0015873) (Paget disease of the nipple), [MONDO:0015872](http://purl.obolibrary.org/obo/MONDO_0015872) (giant adenofibroma of the breast), [MONDO:0020549](http://purl.obolibrary.org/obo/MONDO_0020549) (invasive hydatidiform mole), [MONDO:0015874](http://purl.obolibrary.org/obo/MONDO_0015874) (benign ductal tumor of breast), [MONDO:0016287](http://purl.obolibrary.org/obo/MONDO_0016287) (adenoid basal carcinoma of the cervix uteri), [MONDO:0016286](http://purl.obolibrary.org/obo/MONDO_0016286) (adenoid cystic carcinoma of the cervix uteri), [MONDO:0015871](http://purl.obolibrary.org/obo/MONDO_0015871) (benign breast phyllodes tumor), [MONDO:0016289](http://purl.obolibrary.org/obo/MONDO_0016289) (malignant germ cell tumor of cervix uteri), [MONDO:0015870](http://purl.obolibrary.org/obo/MONDO_0015870) (rare malignant breast tumor), [MONDO:0016288](http://purl.obolibrary.org/obo/MONDO_0016288) (glassy cell carcinoma of the cervix uteri), [MONDO:0003408](http://purl.obolibrary.org/obo/MONDO_0003408) (ovarian primitive germ cell tumor), [MONDO:0016283](http://purl.obolibrary.org/obo/MONDO_0016283) (leiomyosarcoma of the cervix uteri), [MONDO:0016282](http://purl.obolibrary.org/obo/MONDO_0016282) (rhabdomyosarcoma of the cervix uteri), [MONDO:0016285](http://purl.obolibrary.org/obo/MONDO_0016285) (papillary carcinoma of the cervix uteri), [MONDO:0016284](http://purl.obolibrary.org/obo/MONDO_0016284) (primitive neuroectodermal tumor of the cervix uteri), [MONDO:0003768](http://purl.obolibrary.org/obo/MONDO_0003768) (signet ring cell variant cervical mucinous adenocarcinoma), [MONDO:0016280](http://purl.obolibrary.org/obo/MONDO_0016280) (sarcoma of cervix uteri), [MONDO:0006117](http://purl.obolibrary.org/obo/MONDO_0006117) (breast diffuse large b-cell lymphoma), [MONDO:0004296](http://purl.obolibrary.org/obo/MONDO_0004296) (cervical lymphoepithelioma-like carcinoma), [MONDO:0004294](http://purl.obolibrary.org/obo/MONDO_0004294) (gestational ovarian choriocarcinoma), [MONDO:0015876](http://purl.obolibrary.org/obo/MONDO_0015876) (rare vulvovaginal tumor), [MONDO:0015861](http://purl.obolibrary.org/obo/MONDO_0015861) (rare uterine adnexal tumor), [MONDO:0016279](http://purl.obolibrary.org/obo/MONDO_0016279) (adenosarcoma of the cervix uteri), [MONDO:0020538](http://purl.obolibrary.org/obo/MONDO_0020538) (malignant dysgerminomatous germ cell tumor of ovary), [MONDO:0017800](http://purl.obolibrary.org/obo/MONDO_0017800) (Pseudo-Meigs syndrome), [MONDO:0016276](http://purl.obolibrary.org/obo/MONDO_0016276) (high-grade neuroendocrine carcinoma of the cervix uteri), [MONDO:0016275](http://purl.obolibrary.org/obo/MONDO_0016275) (adenocarcinoma of cervix uteri), [MONDO:0016278](http://purl.obolibrary.org/obo/MONDO_0016278) (carcinosarcoma of the cervix uteri), [MONDO:0015981](http://purl.obolibrary.org/obo/MONDO_0015981) (rare genetic gynecological tumor), [MONDO:0016277](http://purl.obolibrary.org/obo/MONDO_0016277) (malignant mixed epithelial and mesenchymal tumor of cervix uteri), [MONDO:0016272](http://purl.obolibrary.org/obo/MONDO_0016272) (transitional cell carcinoma of the corpus uteri), [MONDO:0016271](http://purl.obolibrary.org/obo/MONDO_0016271) (adenoid cystic carcinoma of the corpus uteri), [MONDO:0002207](http://purl.obolibrary.org/obo/MONDO_0002207) (vulval Paget's disease), [MONDO:0016274](http://purl.obolibrary.org/obo/MONDO_0016274) (rare cancer of cervix uteri), [MONDO:0016273](http://purl.obolibrary.org/obo/MONDO_0016273) (malignant germ cell tumor of corpus uteri), [MONDO:0016270](http://purl.obolibrary.org/obo/MONDO_0016270) (low-grade neuroendocrine tumor of the corpus uteri), [MONDO:0003535](http://purl.obolibrary.org/obo/MONDO_0003535) (fallopian tube papillary adenocarcinoma), [MONDO:0003411](http://purl.obolibrary.org/obo/MONDO_0003411) (breast hemangiopericytoma), [MONDO:0004501](http://purl.obolibrary.org/obo/MONDO_0004501) (fallopian tube cystadenofibroma), [MONDO:0006248](http://purl.obolibrary.org/obo/MONDO_0006248) (hydatidiform mole), [MONDO:0003410](http://purl.obolibrary.org/obo/MONDO_0003410) (Wolffian duct adenocarcinoma), [MONDO:0006488](http://purl.obolibrary.org/obo/MONDO_0006488) (vaginal carcinosarcoma), [MONDO:0006487](http://purl.obolibrary.org/obo/MONDO_0006487) (vaginal adenoid cystic carcinoma), [MONDO:0005153](http://purl.obolibrary.org/obo/MONDO_0005153) (cervical adenocarcinoma), [MONDO:0015869](http://purl.obolibrary.org/obo/MONDO_0015869) (rare benign breast tumor), [MONDO:0012913](http://purl.obolibrary.org/obo/MONDO_0012913) (wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome), [MONDO:0017802](http://purl.obolibrary.org/obo/MONDO_0017802) (ovarian fibrothecoma), [MONDO:0013688](http://purl.obolibrary.org/obo/MONDO_0013688) (linear and whorled nevoid hypermelanosis), [MONDO:0017801](http://purl.obolibrary.org/obo/MONDO_0017801) (atypical Meigs syndrome), [MONDO:0015868](http://purl.obolibrary.org/obo/MONDO_0015868) (rare breast tumor), [MONDO:0015867](http://purl.obolibrary.org/obo/MONDO_0015867) (vaginal carcinoma), [MONDO:0016269](http://purl.obolibrary.org/obo/MONDO_0016269) (high-grade neuroendocrine carcinoma of the corpus uteri), [MONDO:0016268](http://purl.obolibrary.org/obo/MONDO_0016268) (papillary carcinoma of the corpus uteri), [MONDO:0016267](http://purl.obolibrary.org/obo/MONDO_0016267) (undifferentiated carcinoma of the corpus uteri), [MONDO:0003509](http://purl.obolibrary.org/obo/MONDO_0003509) (pineal region choriocarcinoma), [MONDO:0013671](http://purl.obolibrary.org/obo/MONDO_0013671) (hydatidiform mole, recurrent, 2), [MONDO:0016266](http://purl.obolibrary.org/obo/MONDO_0016266) (squamous cell carcinoma of the corpus uteri), [MONDO:0003507](http://purl.obolibrary.org/obo/MONDO_0003507) (choriocarcinoma of ovary), [MONDO:0016260](http://purl.obolibrary.org/obo/MONDO_0016260) (uterine corpus rhabdomyosarcoma), [MONDO:0003508](http://purl.obolibrary.org/obo/MONDO_0003508) (choriocarcinoma of the testis), [MONDO:0003989](http://purl.obolibrary.org/obo/MONDO_0003989) (polyembryoma of the ovary), [MONDO:0016263](http://purl.obolibrary.org/obo/MONDO_0016263) (primitive neuroectodermal tumor of the corpus uteri), [MONDO:0016262](http://purl.obolibrary.org/obo/MONDO_0016262) (leiomyosarcoma of the corpus uteri), [MONDO:0003503](http://purl.obolibrary.org/obo/MONDO_0003503) (fallopian tube squamous cell carcinoma), [MONDO:0002534](http://purl.obolibrary.org/obo/MONDO_0002534) (fallopian tube papilloma), [MONDO:0002651](http://purl.obolibrary.org/obo/MONDO_0002651) (anal Paget's disease), [MONDO:0002653](http://purl.obolibrary.org/obo/MONDO_0002653) (Paget disease of the penis), [MONDO:0006335](http://purl.obolibrary.org/obo/MONDO_0006335) (ovarian endometrioid adenocarcinoma), [MONDO:0004033](http://purl.obolibrary.org/obo/MONDO_0004033) (familial ovarian carcinoma), [MONDO:0016254](http://purl.obolibrary.org/obo/MONDO_0016254) (rare variants of adenocarcinoma of the corpus uteri), [MONDO:0016253](http://purl.obolibrary.org/obo/MONDO_0016253) (rare cancer of corpus uteri), [MONDO:0016250](http://purl.obolibrary.org/obo/MONDO_0016250) (rare adenocarcinoma of the breast), [MONDO:0016252](http://purl.obolibrary.org/obo/MONDO_0016252) (rare uterine cancer), [MONDO:0003759](http://purl.obolibrary.org/obo/MONDO_0003759) (childhood ovarian yolk sac tumor), [MONDO:0016251](http://purl.obolibrary.org/obo/MONDO_0016251) (salivary gland type cancer of the breast), [MONDO:0003515](http://purl.obolibrary.org/obo/MONDO_0003515) (fallopian tube teratoma), [MONDO:0003994](http://purl.obolibrary.org/obo/MONDO_0003994) (vagina botryoid rhabdomyosarcoma), [MONDO:0003631](http://purl.obolibrary.org/obo/MONDO_0003631) (cervical serous adenocarcinoma), [MONDO:0003993](http://purl.obolibrary.org/obo/MONDO_0003993) (childhood vagina botryoid rhabdomyosarcoma), [MONDO:0004166](http://purl.obolibrary.org/obo/MONDO_0004166) (hereditary fallopian tube carcinoma), [MONDO:0006344](http://purl.obolibrary.org/obo/MONDO_0006344) (ovarian yolk sac tumor), [MONDO:0013669](http://purl.obolibrary.org/obo/MONDO_0013669) (breast-ovarian cancer, familial, susceptibility to, 4), [MONDO:0004162](http://purl.obolibrary.org/obo/MONDO_0004162) (uterine corpus cellular leiomyoma), [MONDO:0004161](http://purl.obolibrary.org/obo/MONDO_0004161) (uterine corpus apoplectic leiomyoma), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0018944](http://purl.obolibrary.org/obo/MONDO_0018944) (gestational trophoblastic neoplasm), [MONDO:0013253](http://purl.obolibrary.org/obo/MONDO_0013253) (breast-ovarian cancer, familial, susceptibility to, 3), [MONDO:0004537](http://purl.obolibrary.org/obo/MONDO_0004537) (intestinal variant cervical mucinous adenocarcinoma), [MONDO:0003328](http://purl.obolibrary.org/obo/MONDO_0003328) (fallopian tube adenomatoid tumor), [MONDO:0004538](http://purl.obolibrary.org/obo/MONDO_0004538) (endocervical type cervical mucinous adenocarcinoma), [MONDO:0004535](http://purl.obolibrary.org/obo/MONDO_0004535) (childhood choriocarcinoma of the ovary), [MONDO:0003323](http://purl.obolibrary.org/obo/MONDO_0003323) (cervical wilms' tumor), [MONDO:0004413](http://purl.obolibrary.org/obo/MONDO_0004413) (cervical non-keratinizing squamous cell carcinoma), [MONDO:0004530](http://purl.obolibrary.org/obo/MONDO_0004530) (early invasive cervical adenocarcinoma), [MONDO:0006274](http://purl.obolibrary.org/obo/MONDO_0006274) (low grade vulvar intraepithelial neoplasia), [MONDO:0002923](http://purl.obolibrary.org/obo/MONDO_0002923) (uterine corpus endometrial stromal sarcoma), [MONDO:0003458](http://purl.obolibrary.org/obo/MONDO_0003458) (uterine corpus adenofibroma), [MONDO:0003332](http://purl.obolibrary.org/obo/MONDO_0003332) (malignant struma ovarii), [MONDO:0004542](http://purl.obolibrary.org/obo/MONDO_0004542) (glassy cell variant cervical adenosquamous carcinoma), [MONDO:0003333](http://purl.obolibrary.org/obo/MONDO_0003333) (benign struma ovarii), [MONDO:0004661](http://purl.obolibrary.org/obo/MONDO_0004661) (trachea carcinoma in situ), [MONDO:0002481](http://purl.obolibrary.org/obo/MONDO_0002481) (ovary neuroendocrine neoplasm), [MONDO:0004420](http://purl.obolibrary.org/obo/MONDO_0004420) (breast malignant eccrine spiradenoma), [MONDO:0003331](http://purl.obolibrary.org/obo/MONDO_0003331) (ovarian monodermal teratoma), [MONDO:0005198](http://purl.obolibrary.org/obo/MONDO_0005198) (vulvar intraepithelial neoplasia), [MONDO:0011500](http://purl.obolibrary.org/obo/MONDO_0011500) (Becker nevus syndrome), [MONDO:0018369](http://purl.obolibrary.org/obo/MONDO_0018369) (immature ovarian teratoma), [MONDO:0008681](http://purl.obolibrary.org/obo/MONDO_0008681) (WAGR syndrome), [MONDO:0008682](http://purl.obolibrary.org/obo/MONDO_0008682) (Denys-Drash syndrome), [MONDO:0016740](http://purl.obolibrary.org/obo/MONDO_0016740) (choriocarcinoma of the central nervous system), [MONDO:0005602](http://purl.obolibrary.org/obo/MONDO_0005602) (ovarian teratoma), [MONDO:0003666](http://purl.obolibrary.org/obo/MONDO_0003666) (fallopian tube endometrioid adenocarcinoma), [MONDO:0003786](http://purl.obolibrary.org/obo/MONDO_0003786) (childhood testicular choriocarcinoma), [MONDO:0003665](http://purl.obolibrary.org/obo/MONDO_0003665) (cervical endometrioid adenocarcinoma), [MONDO:0006139](http://purl.obolibrary.org/obo/MONDO_0006139) (cervical metaplasia), [MONDO:0006138](http://purl.obolibrary.org/obo/MONDO_0006138) (cervical large cell neuroendocrine carcinoma), [MONDO:0006137](http://purl.obolibrary.org/obo/MONDO_0006137) (cervical intraepithelial neoplasia grade 2/3), [MONDO:0003661](http://purl.obolibrary.org/obo/MONDO_0003661) (breast lymphoma), [MONDO:0006135](http://purl.obolibrary.org/obo/MONDO_0006135) (cervical clear cell adenocarcinoma), [MONDO:0003782](http://purl.obolibrary.org/obo/MONDO_0003782) (uterine corpus epithelioid leiomyosarcoma), [MONDO:0021650](http://purl.obolibrary.org/obo/MONDO_0021650) (uterine corpus neuroendocrine neoplasm), [MONDO:0006134](http://purl.obolibrary.org/obo/MONDO_0006134) (cervical adenosquamous carcinoma), [MONDO:0006133](http://purl.obolibrary.org/obo/MONDO_0006133) (cervical adenoid cystic carcinoma), [MONDO:0006374](http://purl.obolibrary.org/obo/MONDO_0006374) (placental choriocarcinoma), [MONDO:0004193](http://purl.obolibrary.org/obo/MONDO_0004193) (pediatric ovarian dysgerminoma), [MONDO:0006490](http://purl.obolibrary.org/obo/MONDO_0006490) (vaginal squamous cell carcinoma), [MONDO:0020552](http://purl.obolibrary.org/obo/MONDO_0020552) (placental site trophoblastic tumor), [MONDO:0002227](http://purl.obolibrary.org/obo/MONDO_0002227) (ovarian lymphoma), [MONDO:0002223](http://purl.obolibrary.org/obo/MONDO_0002223) (ovarian malignant mesothelioma), [MONDO:0006027](http://purl.obolibrary.org/obo/MONDO_0006027) (breast synovial sarcoma), [MONDO:0003795](http://purl.obolibrary.org/obo/MONDO_0003795) (ovarian small cell carcinoma), [MONDO:0020550](http://purl.obolibrary.org/obo/MONDO_0020550) (gestational choriocarcinoma), [MONDO:0004088](http://purl.obolibrary.org/obo/MONDO_0004088) (cervical basaloid squamous cell carcinoma), [MONDO:0006143](http://purl.obolibrary.org/obo/MONDO_0006143) (cervical squamous cell carcinoma), [MONDO:0018919](http://purl.obolibrary.org/obo/MONDO_0018919) (McCune-Albright syndrome), [MONDO:0006142](http://purl.obolibrary.org/obo/MONDO_0006142) (cervical small cell carcinoma), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0006141](http://purl.obolibrary.org/obo/MONDO_0006141) (cervical mucinous adenocarcinoma, villoglandular variant), [MONDO:0006140](http://purl.obolibrary.org/obo/MONDO_0006140) (cervical mucinous adenocarcinoma, minimal deviation variant), [MONDO:0004082](http://purl.obolibrary.org/obo/MONDO_0004082) (childhood immature teratoma of ovary), [MONDO:0012933](http://purl.obolibrary.org/obo/MONDO_0012933) (breast-ovarian cancer, familial, susceptibility to, 2), [MONDO:0003928](http://purl.obolibrary.org/obo/MONDO_0003928) (uterine corpus myxoid leiomyosarcoma), [MONDO:0001745](http://purl.obolibrary.org/obo/MONDO_0001745) (subserous uterine fibroid), [MONDO:0002159](http://purl.obolibrary.org/obo/MONDO_0002159) (fallopian tube leiomyosarcoma), [MONDO:0003369](http://purl.obolibrary.org/obo/MONDO_0003369) (vagina leiomyosarcoma), [MONDO:0002833](http://purl.obolibrary.org/obo/MONDO_0002833) (fallopian tube transitional cell carcinoma), [MONDO:0004337](http://purl.obolibrary.org/obo/MONDO_0004337) (perianal skin Paget's disease), [MONDO:0002158](http://purl.obolibrary.org/obo/MONDO_0002158) (fallopian tube cancer), [MONDO:0004693](http://purl.obolibrary.org/obo/MONDO_0004693) (cervix uteri carcinoma in situ), [MONDO:0006197](http://purl.obolibrary.org/obo/MONDO_0006197) (endometrial small cell carcinoma), [MONDO:0003481](http://purl.obolibrary.org/obo/MONDO_0003481) (dysgerminoma of ovary), [MONDO:0003819](http://purl.obolibrary.org/obo/MONDO_0003819) (childhood teratoma of the ovary), [MONDO:0003818](http://purl.obolibrary.org/obo/MONDO_0003818) (childhood mature teratoma of the ovary), [MONDO:0003934](http://purl.obolibrary.org/obo/MONDO_0003934) (breast apocrine carcinoma), [MONDO:0018171](http://purl.obolibrary.org/obo/MONDO_0018171) (malignant germ cell tumor of ovary), [MONDO:0004468](http://purl.obolibrary.org/obo/MONDO_0004468) (anal canal Paget's disease), [MONDO:0002162](http://purl.obolibrary.org/obo/MONDO_0002162) (fallopian tube adenosarcoma), [MONDO:0003372](http://purl.obolibrary.org/obo/MONDO_0003372) (vulvar leiomyosarcoma), [MONDO:0003371](http://purl.obolibrary.org/obo/MONDO_0003371) (breast leiomyosarcoma), [MONDO:0016786](http://purl.obolibrary.org/obo/MONDO_0016786) (partial hydatidiform mole), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0016785](http://purl.obolibrary.org/obo/MONDO_0016785) (complete hydatidiform mole), [MONDO:0016787](http://purl.obolibrary.org/obo/MONDO_0016787) (epithelioid trophoblastic tumor), [MONDO:0003907](http://purl.obolibrary.org/obo/MONDO_0003907) (ovarian yolk sac tumor, polyvesicular vitelline pattern), [MONDO:0016784](http://purl.obolibrary.org/obo/MONDO_0016784) (gestational trophoblastic disease), [MONDO:0003905](http://purl.obolibrary.org/obo/MONDO_0003905) (ovarian yolk sac tumor, glandular pattern), [MONDO:0003906](http://purl.obolibrary.org/obo/MONDO_0003906) (ovarian yolk sac tumor, hepatoid pattern), [MONDO:0001845](http://purl.obolibrary.org/obo/MONDO_0001845) (uterine corpus lipoleiomyoma), [MONDO:0001844](http://purl.obolibrary.org/obo/MONDO_0001844) (uterine corpus myxoid leiomyoma), [MONDO:0004319](http://purl.obolibrary.org/obo/MONDO_0004319) (hypercalcemic type ovarian small cell carcinoma), [MONDO:0001846](http://purl.obolibrary.org/obo/MONDO_0001846) (uterine corpus bizarre leiomyoma), [MONDO:0001841](http://purl.obolibrary.org/obo/MONDO_0001841) (uterine corpus epithelioid leiomyoma), [MONDO:0004318](http://purl.obolibrary.org/obo/MONDO_0004318) (pulmonary type ovarian small cell carcinoma), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003589](http://purl.obolibrary.org/obo/MONDO_0003589) (liposarcoma of the ovary), [MONDO:0001843](http://purl.obolibrary.org/obo/MONDO_0001843) (uterus interstitial leiomyoma), [MONDO:0001842](http://purl.obolibrary.org/obo/MONDO_0001842) (uterine corpus dissecting leiomyoma), [MONDO:0002372](http://purl.obolibrary.org/obo/MONDO_0002372) (ovarian monodermal and highly specialized teratoma), [MONDO:0004552](http://purl.obolibrary.org/obo/MONDO_0004552) (microinvasive cervical squamous cell carcinoma), [MONDO:0003581](http://purl.obolibrary.org/obo/MONDO_0003581) (ovarian embryonal carcinoma), [MONDO:0003461](http://purl.obolibrary.org/obo/MONDO_0003461) (fallopian tube adenofibroma), [MONDO:0002490](http://purl.obolibrary.org/obo/MONDO_0002490) (breast sarcoma), [MONDO:0014249](http://purl.obolibrary.org/obo/MONDO_0014249) (multiple fibroadenoma of the breast), [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0000645](http://purl.obolibrary.org/obo/MONDO_0000645) (fallopian tube benign neoplasm), [MONDO:0016096](http://purl.obolibrary.org/obo/MONDO_0016096) (malignant non-dysgerminomatous germ cell tumor of ovary), [MONDO:0016095](http://purl.obolibrary.org/obo/MONDO_0016095) (vaginal rhabdomyosarcoma), [MONDO:0016092](http://purl.obolibrary.org/obo/MONDO_0016092) (serous or mucinous cystadenoma of childhood), [MONDO:0016094](http://purl.obolibrary.org/obo/MONDO_0016094) (vaginal germ cell malignant tumor), [MONDO:0003599](http://purl.obolibrary.org/obo/MONDO_0003599) (vulvar liposarcoma), [MONDO:0004322](http://purl.obolibrary.org/obo/MONDO_0004322) (non-gestational ovarian choriocarcinoma), [MONDO:0003355](http://purl.obolibrary.org/obo/MONDO_0003355) (ovary leiomyosarcoma), [MONDO:0004441](http://purl.obolibrary.org/obo/MONDO_0004441) (childhood ovarian embryonal carcinoma), [MONDO:0002143](http://purl.obolibrary.org/obo/MONDO_0002143) (vaginal yolk sac tumor), [MONDO:0003593](http://purl.obolibrary.org/obo/MONDO_0003593) (breast liposarcoma), [MONDO:0006980](http://purl.obolibrary.org/obo/MONDO_0006980) (struma ovarii), [MONDO:0009273](http://purl.obolibrary.org/obo/MONDO_0009273) (hydatidiform mole, recurrent, 1), [MONDO:0016249](http://purl.obolibrary.org/obo/MONDO_0016249) (hereditary site-specific ovarian cancer syndrome), [MONDO:0016248](http://purl.obolibrary.org/obo/MONDO_0016248) (familial ovarian cancer), [MONDO:0003728](http://purl.obolibrary.org/obo/MONDO_0003728) (breast fibrosarcoma), [MONDO:0001664](http://purl.obolibrary.org/obo/MONDO_0001664) (submucous uterine fibroid), [MONDO:0003966](http://purl.obolibrary.org/obo/MONDO_0003966) (testicular monophasic choriocarcinoma), [MONDO:0002877](http://purl.obolibrary.org/obo/MONDO_0002877) (cervical carcinosarcoma), [MONDO:0002876](http://purl.obolibrary.org/obo/MONDO_0002876) (cervical adenosarcoma), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0007886](http://purl.obolibrary.org/obo/MONDO_0007886) (uterine corpus leiomyoma), [MONDO:0003285](http://purl.obolibrary.org/obo/MONDO_0003285) (fallopian tube leiomyoma), [MONDO:0004013](http://purl.obolibrary.org/obo/MONDO_0004013) (adult vagina botryoid rhabdomyosarcoma), [MONDO:0003281](http://purl.obolibrary.org/obo/MONDO_0003281) (ovarian cystic teratoma), [MONDO:0004490](http://purl.obolibrary.org/obo/MONDO_0004490) (gestational uterine corpus choriocarcinoma), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0017327](http://purl.obolibrary.org/obo/MONDO_0017327) (primary non-gestational choriocarcinoma of ovary), [MONDO:0008177](http://purl.obolibrary.org/obo/MONDO_0008177) (extramammary Paget disease), [MONDO:0003855](http://purl.obolibrary.org/obo/MONDO_0003855) (immature teratoma of ovary), [MONDO:0008734](http://purl.obolibrary.org/obo/MONDO_0008734) (adrenocortical carcinoma, hereditary), [MONDO:0006208](http://purl.obolibrary.org/obo/MONDO_0006208) (fallopian tube serous adenocarcinoma), [MONDO:0006207](http://purl.obolibrary.org/obo/MONDO_0006207) (fallopian tube carcinosarcoma), [MONDO:0002761](http://purl.obolibrary.org/obo/MONDO_0002761) (cervical verrucous carcinoma), [MONDO:0006206](http://purl.obolibrary.org/obo/MONDO_0006206) (fallopian tube carcinoma), [MONDO:0003851](http://purl.obolibrary.org/obo/MONDO_0003851) (ovarian fetiform teratoma), [MONDO:0002881](http://purl.obolibrary.org/obo/MONDO_0002881) (vaginal adenosarcoma), [MONDO:0003852](http://purl.obolibrary.org/obo/MONDO_0003852) (ovarian solid teratoma), [MONDO:0006445](http://purl.obolibrary.org/obo/MONDO_0006445) (testicular choriocarcinoma), [MONDO:0017799](http://purl.obolibrary.org/obo/MONDO_0017799) (Meigs syndrome), [MONDO:0011450](http://purl.obolibrary.org/obo/MONDO_0011450) (breast-ovarian cancer, familial, susceptibility to, 1), [MONDO:0008167](http://purl.obolibrary.org/obo/MONDO_0008167) (dermoid cyst of ovary), [MONDO:0008168](http://purl.obolibrary.org/obo/MONDO_0008168) (ovarian fibroma (disease)), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0002859](http://purl.obolibrary.org/obo/MONDO_0002859) (breast rhabdomyosarcoma), [MONDO:0003703](http://purl.obolibrary.org/obo/MONDO_0003703) (uterine corpus leiomyomatosis), [MONDO:0008841](http://purl.obolibrary.org/obo/MONDO_0008841) (ataxia-telangiectasia with generalized skin pigmentation and early death), [MONDO:0002858](http://purl.obolibrary.org/obo/MONDO_0002858) (ovary rhabdomyosarcoma), [MONDO:0003704](http://purl.obolibrary.org/obo/MONDO_0003704) (uterine corpus diffuse leiomyomatosis), [MONDO:0000554](http://purl.obolibrary.org/obo/MONDO_0000554) (endocervical adenocarcinoma), [MONDO:0003702](http://purl.obolibrary.org/obo/MONDO_0003702) (uterus intravascular leiomyomatosis), [MONDO:0003820](http://purl.obolibrary.org/obo/MONDO_0003820) (mature ovarian teratoma), [MONDO:0004239](http://purl.obolibrary.org/obo/MONDO_0004239) (cervical keratinizing squamous cell carcinoma), [MONDO:0003821](http://purl.obolibrary.org/obo/MONDO_0003821) (ovarian biphasic or triphasic teratoma), [MONDO:0003024](http://purl.obolibrary.org/obo/MONDO_0003024) (breast angiosarcoma), [MONDO:0003383](http://purl.obolibrary.org/obo/MONDO_0003383) (fallopian tube clear cell adenocarcinoma), [MONDO:0019965](http://purl.obolibrary.org/obo/MONDO_0019965) (rare benign ovarian tumor), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0002746](http://purl.obolibrary.org/obo/MONDO_0002746) (fallopian tube adenocarcinoma), [MONDO:0002742](http://purl.obolibrary.org/obo/MONDO_0002742) (cervical mucinous adenocarcinoma), [MONDO:0003710](http://purl.obolibrary.org/obo/MONDO_0003710) (ovarian mixed germ cell neoplasm), [MONDO:0003952](http://purl.obolibrary.org/obo/MONDO_0003952) (adult central nervous system choriocarcinoma), [MONDO:0002744](http://purl.obolibrary.org/obo/MONDO_0002744) (fallopian tube mucinous adenocarcinoma), [MONDO:0004489](http://purl.obolibrary.org/obo/MONDO_0004489) (fallopian tube gestational choriocarcinoma), [MONDO:0007635](http://purl.obolibrary.org/obo/MONDO_0007635) (Frasier syndrome), [MONDO:0003035](http://purl.obolibrary.org/obo/MONDO_0003035) (ovarian angiosarcoma), [MONDO:0004243](http://purl.obolibrary.org/obo/MONDO_0004243) (vulvar proximal-type epithelioid sarcoma), [MONDO:0004120](http://purl.obolibrary.org/obo/MONDO_0004120) (Bartholin's gland small cell carcinoma), [MONDO:0005210](http://purl.obolibrary.org/obo/MONDO_0005210) (uterine corpus sarcoma), [MONDO:0003392](http://purl.obolibrary.org/obo/MONDO_0003392) (fallopian tube germ cell cancer), [MONDO:0004360](http://purl.obolibrary.org/obo/MONDO_0004360) (breast osteosarcoma), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0021796](http://purl.obolibrary.org/obo/GO_0021796) (cerebral cortex regionalization), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0007259](http://purl.obolibrary.org/obo/GO_0007259) (JAK-STAT cascade), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:0090104](http://purl.obolibrary.org/obo/GO_0090104) (pancreatic epsilon cell differentiation), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0030261](http://purl.obolibrary.org/obo/GO_0030261) (chromosome condensation), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0006975](http://purl.obolibrary.org/obo/GO_0006975) (DNA damage induced protein phosphorylation), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0021543](http://purl.obolibrary.org/obo/GO_0021543) (pallium development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0001833](http://purl.obolibrary.org/obo/GO_0001833) (inner cell mass cell proliferation), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0061351](http://purl.obolibrary.org/obo/GO_0061351) (neural precursor cell proliferation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045665](http://purl.obolibrary.org/obo/GO_0045665) (negative regulation of neuron differentiation), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0021778](http://purl.obolibrary.org/obo/GO_0021778) (oligodendrocyte cell fate specification), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0003311](http://purl.obolibrary.org/obo/GO_0003311) (pancreatic D cell differentiation), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0042162](http://purl.obolibrary.org/obo/GO_0042162) (telomeric DNA binding), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:1990426](http://purl.obolibrary.org/obo/GO_1990426) (mitotic recombination-dependent replication fork processing), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:2001224](http://purl.obolibrary.org/obo/GO_2001224) (positive regulation of neuron migration), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0009786](http://purl.obolibrary.org/obo/GO_0009786) (regulation of asymmetric cell division), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003322](http://purl.obolibrary.org/obo/GO_0003322) (pancreatic A cell development), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0007171](http://purl.obolibrary.org/obo/GO_0007171) (activation of transmembrane receptor protein tyrosine kinase activity), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0021918](http://purl.obolibrary.org/obo/GO_0021918) (regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment), [GO:0021912](http://purl.obolibrary.org/obo/GO_0021912) (regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0021913](http://purl.obolibrary.org/obo/GO_0021913) (regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:1904937](http://purl.obolibrary.org/obo/GO_1904937) (sensory neuron migration), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0003009](http://purl.obolibrary.org/obo/GO_0003009) (skeletal muscle contraction), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0072425](http://purl.obolibrary.org/obo/GO_0072425) (signal transduction involved in G2 DNA damage checkpoint), [GO:0016572](http://purl.obolibrary.org/obo/GO_0016572) (histone phosphorylation), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0045739](http://purl.obolibrary.org/obo/GO_0045739) (positive regulation of DNA repair), [GO:0021905](http://purl.obolibrary.org/obo/GO_0021905) (forebrain-midbrain boundary formation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0021902](http://purl.obolibrary.org/obo/GO_0021902) (commitment of neuronal cell to specific neuron type in forebrain), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000793](http://purl.obolibrary.org/obo/GO_0000793) (condensed chromosome), [GO:0071681](http://purl.obolibrary.org/obo/GO_0071681) (cellular response to indole-3-methanol), [GO:0021593](http://purl.obolibrary.org/obo/GO_0021593) (rhombomere morphogenesis), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0030856](http://purl.obolibrary.org/obo/GO_0030856) (regulation of epithelial cell differentiation), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0030858](http://purl.obolibrary.org/obo/GO_0030858) (positive regulation of epithelial cell differentiation), [GO:0051298](http://purl.obolibrary.org/obo/GO_0051298) (centrosome duplication), [GO:0001757](http://purl.obolibrary.org/obo/GO_0001757) (somite specification), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0010225](http://purl.obolibrary.org/obo/GO_0010225) (response to UV-C), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0014823](http://purl.obolibrary.org/obo/GO_0014823) (response to activity), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0035066](http://purl.obolibrary.org/obo/GO_0035066) (positive regulation of histone acetylation), [GO:0060221](http://purl.obolibrary.org/obo/GO_0060221) (retinal rod cell differentiation), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:2000617](http://purl.obolibrary.org/obo/GO_2000617) (positive regulation of histone H3-K9 acetylation), [GO:0098598](http://purl.obolibrary.org/obo/GO_0098598) (learned vocalization behavior or vocal learning), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0032465](http://purl.obolibrary.org/obo/GO_0032465) (regulation of cytokinesis), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:2000178](http://purl.obolibrary.org/obo/GO_2000178) (negative regulation of neural precursor cell proliferation), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0030049](http://purl.obolibrary.org/obo/GO_0030049) (muscle filament sliding), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0003002](http://purl.obolibrary.org/obo/GO_0003002) (regionalization), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0048476](http://purl.obolibrary.org/obo/GO_0048476) (Holliday junction resolvase complex), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:2000620](http://purl.obolibrary.org/obo/GO_2000620) (positive regulation of histone H4-K16 acetylation), [GO:0030155](http://purl.obolibrary.org/obo/GO_0030155) (regulation of cell adhesion), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0010564](http://purl.obolibrary.org/obo/GO_0010564) (regulation of cell cycle process), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0007098](http://purl.obolibrary.org/obo/GO_0007098) (centrosome cycle), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0009950](http://purl.obolibrary.org/obo/GO_0009950) (dorsal/ventral axis specification), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0070200](http://purl.obolibrary.org/obo/GO_0070200) (establishment of protein localization to telomere), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0061180](http://purl.obolibrary.org/obo/GO_0061180) (mammary gland epithelium development), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0042660](http://purl.obolibrary.org/obo/GO_0042660) (positive regulation of cell fate specification), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0009048](http://purl.obolibrary.org/obo/GO_0009048) (dosage compensation by inactivation of X chromosome), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0042670](http://purl.obolibrary.org/obo/GO_0042670) (retinal cone cell differentiation), [GO:0033365](http://purl.obolibrary.org/obo/GO_0033365) (protein localization to organelle), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0010389](http://purl.obolibrary.org/obo/GO_0010389) (regulation of G2/M transition of mitotic cell cycle), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0010484](http://purl.obolibrary.org/obo/GO_0010484) (H3 histone acetyltransferase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0090276](http://purl.obolibrary.org/obo/GO_0090276) (regulation of peptide hormone secretion), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0000794](http://purl.obolibrary.org/obo/GO_0000794) (condensed nuclear chromosome), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0045717](http://purl.obolibrary.org/obo/GO_0045717) (negative regulation of fatty acid biosynthetic process), [GO:0016459](http://purl.obolibrary.org/obo/GO_0016459) (myosin complex), [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex), [GO:0120008](http://purl.obolibrary.org/obo/GO_0120008) (positive regulation of glutamatergic neuron differentiation), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0004925](http://purl.obolibrary.org/obo/GO_0004925) (prolactin receptor activity), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), [GO:0085020](http://purl.obolibrary.org/obo/GO_0085020) (protein K6-linked ubiquitination), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:1901142](http://purl.obolibrary.org/obo/GO_1901142) (insulin metabolic process), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0003774](http://purl.obolibrary.org/obo/GO_0003774) (motor activity), [GO:0000142](http://purl.obolibrary.org/obo/GO_0000142) (cellular bud neck contractile ring), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0031436](http://purl.obolibrary.org/obo/GO_0031436) (BRCA1-BARD1 complex), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0000146](http://purl.obolibrary.org/obo/GO_0000146) (microfilament motor activity), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0051574](http://purl.obolibrary.org/obo/GO_0051574) (positive regulation of histone H3-K9 methylation), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0051572](http://purl.obolibrary.org/obo/GO_0051572) (negative regulation of histone H3-K4 methylation), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0051571](http://purl.obolibrary.org/obo/GO_0051571) (positive regulation of histone H3-K4 methylation), [GO:0070512](http://purl.obolibrary.org/obo/GO_0070512) (positive regulation of histone H4-K20 methylation), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0033600](http://purl.obolibrary.org/obo/GO_0033600) (negative regulation of mammary gland epithelial cell proliferation), [GO:0061034](http://purl.obolibrary.org/obo/GO_0061034) (olfactory bulb mitral cell layer development), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0043966](http://purl.obolibrary.org/obo/GO_0043966) (histone H3 acetylation), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0044818](http://purl.obolibrary.org/obo/GO_0044818) (mitotic G2/M transition checkpoint), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0000910](http://purl.obolibrary.org/obo/GO_0000910) (cytokinesis), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0007435](http://purl.obolibrary.org/obo/GO_0007435) (salivary gland morphogenesis), [GO:0022027](http://purl.obolibrary.org/obo/GO_0022027) (interkinetic nuclear migration), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0032982](http://purl.obolibrary.org/obo/GO_0032982) (myosin filament), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0038161](http://purl.obolibrary.org/obo/GO_0038161) (prolactin signaling pathway), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0000800](http://purl.obolibrary.org/obo/GO_0000800) (lateral element), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048505](http://purl.obolibrary.org/obo/GO_0048505) (regulation of timing of cell differentiation), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0000132](http://purl.obolibrary.org/obo/GO_0000132) (establishment of mitotic spindle orientation), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0070094](http://purl.obolibrary.org/obo/GO_0070094) (positive regulation of glucagon secretion), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0006349](http://purl.obolibrary.org/obo/GO_0006349) (regulation of gene expression by genetic imprinting), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0070412](http://purl.obolibrary.org/obo/GO_0070412) (R-SMAD binding), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0070410](http://purl.obolibrary.org/obo/GO_0070410) (co-SMAD binding), [GO:0070531](http://purl.obolibrary.org/obo/GO_0070531) (BRCA1-A complex), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 57.12%
- [GO:0035883](http://purl.obolibrary.org/obo/GO_0035883) (enteroendocrine cell differentiation) 51.21%
- [GO:0060219](http://purl.obolibrary.org/obo/GO_0060219) (camera-type eye photoreceptor cell differentiation) 50.81%
- [GO:0046530](http://purl.obolibrary.org/obo/GO_0046530) (photoreceptor cell differentiation) 50.81%
- [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development) 50.81%
- [GO:0001754](http://purl.obolibrary.org/obo/GO_0001754) (eye photoreceptor cell differentiation) 50.81%
- [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration) 50.40%
- [GO:0090104](http://purl.obolibrary.org/obo/GO_0090104) (pancreatic epsilon cell differentiation) 50.40%
- [GO:0061180](http://purl.obolibrary.org/obo/GO_0061180) (mammary gland epithelium development) 50.40%
- [GO:0061034](http://purl.obolibrary.org/obo/GO_0061034) (olfactory bulb mitral cell layer development) 50.40%
- [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development) 50.40%
- [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development) 50.40%
- [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development) 50.40%
- [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development) 50.40%
- [GO:0060221](http://purl.obolibrary.org/obo/GO_0060221) (retinal rod cell differentiation) 50.40%


